FDA Cites Benefits of Merck HIV Drug

September 1st, 2007 in Medicine & Health / HIV & AIDS

(AP) -- A new HIV-fighting drug from Merck & Co. appears superior to options for patients who have stopped responding to available drugs, federal regulators said Friday.

---

Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .

---